These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 6427880

  • 1. Factor VIII-related activities after 1-deamino-8-D-arginine vasopressin in multicentric reticulohistiocytosis.
    Taddeo U, Trotta F, Menegale G, Ballerini G.
    Ric Clin Lab; 1984; 14(1):37-9. PubMed ID: 6427880
    [Abstract] [Full Text] [Related]

  • 2. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H, Itoh M, Kobayashi I, Sakuragawa N, Shibata A.
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [Abstract] [Full Text] [Related]

  • 3. [Studies on the properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) in normal individuals (author's transl)].
    Takahashi H, Itoh M, Kobayashi I, Hattori A, Takahashi K, Sakuragawa N, Shibata A, Tsukada T.
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):907-17. PubMed ID: 6785953
    [No Abstract] [Full Text] [Related]

  • 4. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA, Peake IR, Allen N, Davies BL, Furlong RA, Bloom AL.
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [Abstract] [Full Text] [Related]

  • 5. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL, Doyle JJ, Israels ED, Winter JS, Cheang MS, Walker RD, Bishop AJ.
    Lancet; 1985 Jun 08; 1(8441):1293-4. PubMed ID: 2860491
    [Abstract] [Full Text] [Related]

  • 6. 1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor.
    Muhm M, Grois N, Kier P, Stümpflen A, Kyrle P, Pabinger I, Bettelheim P, Hinterberger W, Lechner K.
    Haemostasis; 1990 Jun 08; 20(1):15-20. PubMed ID: 2108912
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of DDAVP on plasma level of factor XII.
    Nenci GG, Berrettini M, De Cunto M, Agnelli G.
    Br J Haematol; 1983 Jul 08; 54(3):489-92. PubMed ID: 6407513
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Accumulative effect of DDAVP and heparin in increasing plasma factor VIII levels.
    Rock G, Palmer DS.
    Vox Sang; 1981 Jul 08; 41(1):56-60. PubMed ID: 6798759
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP.
    Brommer EJ, Derkx FH, Barrett-Bergshoeff MM, Schalekamp MA.
    Thromb Haemost; 1984 Feb 28; 51(1):42-4. PubMed ID: 6426080
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DDAVP factor VIII concentrate and its properties in vivo and in vitro.
    Nilsson IM, Mikaelsson M, Vilhardt H, Walter H.
    Thromb Res; 1979 Feb 28; 15(1-2):263-71. PubMed ID: 314686
    [No Abstract] [Full Text] [Related]

  • 18. DDAVP: does the drug have a direct effect on the vessel wall?
    Barnhart MI, Chen S, Lusher JM.
    Thromb Res; 1983 Jul 15; 31(2):239-53. PubMed ID: 6415852
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.